These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12044006)

  • 1. Cardiovascular disease and lipid management in New Zealand: progress at last!
    Ellis CJ; Scott R
    N Z Med J; 2002 Apr; 115(1152):197-9. PubMed ID: 12044006
    [No Abstract]   [Full Text] [Related]  

  • 2. More about cardiovascular disease and lipid management in New Zealand.
    Metcalfe S; Moodie P
    N Z Med J; 2002 Oct; 115(1163):U203. PubMed ID: 12552309
    [No Abstract]   [Full Text] [Related]  

  • 3. Case studies in lipid management.
    Tallis GA; Popplewell PY; Phillips PJ
    Aust Fam Physician; 1995 Sep; 24(9):1627-31, 1634-5, 1637. PubMed ID: 7487648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
    Tonkin A; Barter P; Best J; Boyden A; Furler J; Hossack K; Sullivan D; Thompson P; Vale M; Cooper C; Robinson M; Clune E; ;
    Heart Lung Circ; 2005 Dec; 14(4):275-91. PubMed ID: 16361000
    [No Abstract]   [Full Text] [Related]  

  • 5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New cholesterol guidelines emphasize risk assessment.
    Grundy SM
    Am J Manag Care; 2002 Jan; Suppl():1, 3. PubMed ID: 11833450
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the lifetime cardiovascular risk of New Zealanders.
    Stewart RA; White HD
    N Z Med J; 2007 Sep; 120(1261):U2708. PubMed ID: 17853930
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of diabetic dyslipidemia.
    Del Pilar Solano M; Goldberg RB
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):1-25, v. PubMed ID: 15752919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G; Jungner I
    J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study suggests statins for diabetics with healthy LDL cholesterol levels.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):1-2, 6-7. PubMed ID: 15452942
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational prescribing of statins.
    Purcell H; Daly C; Sheppard M; Morrell J
    Practitioner; 2001 Nov; 245(1628):957-9, 962-3. PubMed ID: 11727350
    [No Abstract]   [Full Text] [Related]  

  • 17. [Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?].
    Fretheim A; Bjørndal A; Oxman AD; Dyrdal A; Golding M; Ose L; Reikvam A; Teisberg P
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2287-8. PubMed ID: 12448270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    Geriatr Nurs; 2006; 27(3):142-8. PubMed ID: 16757384
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.